Maravai LifeSciences makes nucleic acid products and bioprocess testing kits and services for drug developers and researchers. MRVI reports earnings on Wed, Nov 4, 2026. Over the past 90 days StreetAlpha recorded 1 whale options trade in MRVI, 0% of them bullish and 100% bearish.
Prices, price targets and earnings estimates for MRVI are shown to AI Starter and AI Pro members. Ratings, flow and news are open to everyone.See plansSign in
Only 2 firms rated MRVI in the past 90 days, not enough for a consensus
Average 12-month target
Price targets for MRVIThe average, highest and lowest analyst targets and the target chart are shown to AI Starter and AI Pro members.See plansSign in
Latest rating changes
UBSMaintained
Sep 9Hold
Wells FargoMaintained
Aug 7Buy
Date
Firm
Action
Rating
Price target
Sep 9
UBS
Maintained
Hold
Aug 7
Wells Fargo
Maintained
Buy
Loading…
Whale Options Flow
90D
No whale options trades in MRVI in the last 90 days.
Total alerts
1
Bullish
0
0%
Bearish
1
100%
Date span
Aug 19 – Aug 19
Loading…
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether MRVI is in one of them and how their past MRVI trades turned out.
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About Maravai Lifesciences Holdings
Maravai LifeSciences is a life sciences company based in San Diego, California. Its TriLink segment makes modified nucleic acids for customers' research, therapeutic and vaccine programs, and sells research products for labeling and detecting proteins in cells and tissue samples. Its Cygnus segment sells kits and products for testing biologic drug manufacturing, including host cell protein and impurity detection and viral clearance prediction, and offers services such as custom antibody development and mass spectrometry. Its customers include drug developers, vaccine makers, researchers and biologic drug manufacturers.
